These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11570696)

  • 1. Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat.
    Carthew P; Lee PN; Edwards RE; Heydon RT; Nolan BM; Martin EA
    Arch Toxicol; 2001 Aug; 75(6):375-80. PubMed ID: 11570696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.
    Carthew P; Martin EA; White IN; De Matteis F; Edwards RE; Dorman BM; Heydon RT; Smith LL
    Cancer Res; 1995 Feb; 55(3):544-7. PubMed ID: 7834623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.
    Stanley LA; Carthew P; Davies R; Higginson F; Martin E; Styles JA
    Cancer Lett; 2001 Sep; 171(1):27-35. PubMed ID: 11485825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation.
    Carthew P; Rich KJ; Martin EA; De Matteis F; Lim CK; Manson MM; Festing MF; White IN; Smith LL
    Carcinogenesis; 1995 Jun; 16(6):1299-304. PubMed ID: 7788846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the formation and accumulation of liver DNA adducts in mice chronically exposed to tamoxifen.
    Martin EA; Carthew P; White IN; Heydon RT; Gaskell M; Mauthe RJ; Turteltaub KW; Smith LL
    Carcinogenesis; 1997 Nov; 18(11):2209-15. PubMed ID: 9395223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
    Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
    Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis.
    Tryndyak VP; Muskhelishvili L; Kovalchuk O; Rodriguez-Juarez R; Montgomery B; Churchwell MI; Ross SA; Beland FA; Pogribny IP
    Carcinogenesis; 2006 Aug; 27(8):1713-20. PubMed ID: 16632870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.
    White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH
    Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Luo FQ; Wang CX; Pittman B
    Arch Toxicol; 1999 Sep; 73(7):394-402. PubMed ID: 10550482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis.
    Souliotis VL; Chhabra S; Anderson LM; Kyrtopoulos SA
    Carcinogenesis; 1995 Oct; 16(10):2381-7. PubMed ID: 7586139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.
    Waddell WJ; Crooks NH; Carmichael PL
    Toxicol Sci; 2004 May; 79(1):38-40. PubMed ID: 14976343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen.
    Martin EA; Rich KJ; White IN; Woods KL; Powles TJ; Smith LL
    Carcinogenesis; 1995 Jul; 16(7):1651-4. PubMed ID: 7614701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the major DNA adducts in the liver of rats chronically exposed to tamoxifen for 18 months.
    Firozi PF; Vulimiri SV; Rajaniemi H; Hemminki K; Dragan Y; Pitot HC; DiGiovanni J; Zhu YH; Li D
    Chem Biol Interact; 2000 Apr; 126(1):33-43. PubMed ID: 10826652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
    Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
    Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.
    Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R
    Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.
    White IN; Carthew P; Davies R; Styles J; Brown K; Brown JE; Smith LL; Martin EA
    Carcinogenesis; 2001 Apr; 22(4):553-7. PubMed ID: 11285188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and repair of DNA adducts in vinyl chloride- and vinyl fluoride-induced carcinogenesis.
    Swenberg JA; Bogdanffy MS; Ham A; Holt S; Kim A; Morinello EJ; Ranasinghe A; Scheller N; Upton PB
    IARC Sci Publ; 1999; (150):29-43. PubMed ID: 10626206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.